Clinical Trial Update: TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus [Phase 2]

View source ↗

Summary

Phase 2 trial updating status for TriCalm Hydrogel in treating immunotherapy-related pruritus; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• TriCalm Hydrogel

Snippet

Sponsor: University of California, San Diego | Conditions: Immunotherapy-related Pruritus | Phase 2 | Status: RECRUITING